I.M.I.M.NakshabendiI.M.I.M. i inni, Effect of omeprazole therapy on the survival of Helicobacter pylori, urease activity, and antral gastric histology in patients with duodenal ulcer, „Helicobacter”, 1 (3), 1996, s. 155–158, DOI: 10.1111/j.1523-5378.1996.tb00030.x, PMID: 9398897(ang.).
LorenaL.PochiniLorenaL., MariafrancescaM.ScaliseMariafrancescaM., CesareC.IndiveriCesareC., Inactivation by omeprazole of the carnitine transporter (OCTN2) reconstituted in liposomes, „Chemico-Biological Interactions”, 179 (2-3), 2009, s. 394–401, DOI: 10.1016/j.cbi.2008.10.052, PMID: 19041296 [dostęp 2021-03-26](ang.).
C.A.C.A.StedmanC.A.C.A., M.L.M.L.BarclayM.L.M.L., Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors, „Alimentary Pharmacology & Therapeutics”, 14 (8), 2000, s. 963–978, DOI: 10.1046/j.1365-2036.2000.00788.x, ISSN0269-2813, PMID: 10930890(ang.).
Wei C.W.C.LauWei C.W.C., Paul A.P.A.GurbelPaul A.P.A., The drug-drug interaction between proton pump inhibitors and clopidogrel, „Canadian Medical Association Journal”, 180 (7), 2009, s. 699–700, DOI: 10.1503/cmaj.090251, PMID: 19332744, PMCID: PMC2659824(ang.).
Nicholas B.N.B.NorgardNicholas B.N.B., Kathryn D.K.D.MathewsKathryn D.K.D., Geoffrey C.G.C.WallGeoffrey C.G.C., Drug-drug interaction between clopidogrel and the proton pump inhibitors, „The Annals of Pharmacotherapy”, 43 (7), 2009, s. 1266–1274, DOI: 10.1345/aph.1M051, PMID: 19470853(ang.).
C.C.Pauli-MagnusC.C. i inni, Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein, „Naunyn-Schmiedeberg's Archives of Pharmacology”, 364 (6), 2001, s. 551–557, DOI: 10.1007/s00210-001-0489-7, PMID: 11770010 [dostęp 2021-03-26](ang.).
F.F.MirshahiF.F. i inni, Omeprazole may exert both a bacteriostatic and a bacteriocidal effect on the growth of Helicobacter pylori (NCTC 11637) in vitro by inhibiting bacterial urease activity, „Journal of Clinical Pathology”, 51 (3), 1998, s. 220–224, PMID: 9659264, PMCID: PMC500643(ang.).
I.M.I.M.NakshabendiI.M.I.M. i inni, Effect of omeprazole therapy on the survival of Helicobacter pylori, urease activity, and antral gastric histology in patients with duodenal ulcer, „Helicobacter”, 1 (3), 1996, s. 155–158, DOI: 10.1111/j.1523-5378.1996.tb00030.x, PMID: 9398897(ang.).
LorenaL.PochiniLorenaL., MariafrancescaM.ScaliseMariafrancescaM., CesareC.IndiveriCesareC., Inactivation by omeprazole of the carnitine transporter (OCTN2) reconstituted in liposomes, „Chemico-Biological Interactions”, 179 (2-3), 2009, s. 394–401, DOI: 10.1016/j.cbi.2008.10.052, PMID: 19041296 [dostęp 2021-03-26](ang.).
C.A.C.A.StedmanC.A.C.A., M.L.M.L.BarclayM.L.M.L., Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors, „Alimentary Pharmacology & Therapeutics”, 14 (8), 2000, s. 963–978, DOI: 10.1046/j.1365-2036.2000.00788.x, ISSN0269-2813, PMID: 10930890(ang.).
Wei C.W.C.LauWei C.W.C., Paul A.P.A.GurbelPaul A.P.A., The drug-drug interaction between proton pump inhibitors and clopidogrel, „Canadian Medical Association Journal”, 180 (7), 2009, s. 699–700, DOI: 10.1503/cmaj.090251, PMID: 19332744, PMCID: PMC2659824(ang.).
Nicholas B.N.B.NorgardNicholas B.N.B., Kathryn D.K.D.MathewsKathryn D.K.D., Geoffrey C.G.C.WallGeoffrey C.G.C., Drug-drug interaction between clopidogrel and the proton pump inhibitors, „The Annals of Pharmacotherapy”, 43 (7), 2009, s. 1266–1274, DOI: 10.1345/aph.1M051, PMID: 19470853(ang.).
C.C.Pauli-MagnusC.C. i inni, Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein, „Naunyn-Schmiedeberg's Archives of Pharmacology”, 364 (6), 2001, s. 551–557, DOI: 10.1007/s00210-001-0489-7, PMID: 11770010 [dostęp 2021-03-26](ang.).